CHRISTOPHER HOVER: Open Payments
NPI 1275105892 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 39 payments from 14 companies in 2025. Trend: 2023 $656 · 2024 $1,072 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Valinor Pharma, LLC | 18 | $194 |
| TerSera Therapeutics LLC | 3 | $110 |
| Impel Pharmaceuticals LLC | 4 | $78 |
| SCILEX PHARMACEUTICALS INC. | 4 | $73 |
| Boston Scientific Corporation | 1 | $42 |
| Ossur Americas, Inc. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Averitas Pharma Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| AppliedVR Inc | 1 | $16 |
Products named: MOVANTIK, Prialt, TRUDHESA, ZTLido, WaveWriter Alpha Prime 16, Unloader One X, RELISTOR, QUTENZA.
Industry payments across DE — which companies pay providers there.
